- Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures
- New loci and candidate genes in spring two-rowed barley detected through meta-analysis of a field trial European network
- Luteolin as potential treatment for Huntington's disease: Insights from a transgenic mouse model
- NMR structures and magnetic force spectroscopy studies of small molecules binding to models of an RNA CAG repeat expansion
- Glymphatic influx and clearance are perturbed in Huntington's disease
- Identification and validation of oxidative stress-related diagnostic markers for recurrent pregnancy loss: insights from machine learning and molecular analysis
- Progress of Exosomal MicroRNAs and Traditional Chinese Medicine Monomers in Neurodegenerative Diseases
- Improved Mathematical Models of Parkinson's Disease with Hopf Bifurcation and Huntington's Disease with Chaos
- Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system
- Dermal Fibroblast Cell Line from a Patient with the Huntington's Disease as a Promising Model for Studying Disease Pathogenesis: Production and Characterization
- Psychiatric symptoms of Huntington's disease
- Spinocerebellar ataxia type 10 and Huntington disease-like 2 in Venezuela: Further evidence of two different ancestral founder effects
- Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington's Disease: A Review of Data from Mouse Models
- Huntington's Disease-Related Mortality Patterns: A Two-Decade Analysis of Mortality Trends in the United States, from 1999-2019
- Rasch Measurement Theory (RMT) Analyses of the Huntington's Disease Everyday Functioning (Hi-DEF) to Evaluate Item Fit and Performance
- Circadian Interventions in Preclinical Models of Huntington's Disease: A Narrative Review
- Understanding the Mechanism of Ferroptosis in Neurodegenerative Diseases
- Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases
- Metabolic Reprogramming of Astrocytes in Pathological Conditions: Implications for Neurodegenerative Diseases
- Microglia in Neurodegenerative Diseases
- Nuclear proteasomes buffer cytoplasmic proteins during autophagy compromise
- Sympathetic Stimulation Can Compensate for Hypocalcaemia-Induced Bradycardia in Human and Rabbit Sinoatrial Node Cells
- Novel iGluSnFR3 variants with improved kinetics and dynamic range for tracking high frequency firing at glutamatergic synapses
- The NeuroBioBank Whole-Genome Catalog: Sequencing from human brain donors with central nervous system disorders
- Skin Tau Quantification as a Novel Biomarker in Huntington's Disease
- APE1: A critical focus in neurodegenerative conditions
- Neurosurgical gene therapy for central nervous system diseases
- Preclinical evaluation of the novel [(18)F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
- FibrilPaint targets amyloid fibrils for ubiquitination
- Optical coherence tomography measurements in Huntington's disease: a systematic review and meta-analysis
- Pathogenic TDP-43 accelerates the generation of toxic exon1 HTT in Huntington's disease knock-in mice
- PMS2 has both pro-mutagenic and anti-mutagenic effects on repeat instability in the Repeat Expansion Diseases
- AI-based mining of biomedical literature: Applications for drug repurposing for the treatment of dementia
- Current Overview on the Use of Nanosized Drug Delivery Systems in the Treatment of Neurodegenerative Diseases
- Acute Activation of Genes Through Transcriptional Condensates Impact Non-target Genes in a Chromatin Domain
- Intra-individual variability in the effects of transcranial directcurrent stimulation on free choice saccade behaviour
- Medial Entorhinal VIP-expressing interneurons receive direct input from Anterior Dorsal Thalamus and are critical for spatial memory
- Neurofilaments in neurologic disease
- Fibril Paint: a class of amyloid-targeting peptides
- Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders
- Impact of federal antipsychotic use policy in nursing homes on new diagnoses for approved indications in dementia residents
- Mutant huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
- Trial to assess the tolerability of using felodipine to upregulate autophagy as a treatment of Huntington's disease (FELL-HD): a phase II, single-centre, open-label, dose-finding trial protocol
- Progress of ATM inhibitors: Opportunities and challenges
- Unraveling mitochondrial dysfunction: comprehensive perspectives on its impact on neurodegenerative diseases
- Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease
- Transcriptomics analysis reveals potential regulatory role of nSMase2 (Smpd3) in nervous system development and function of middle-aged mouse brains
- Molecular targets of caffeine in the central nervous system
- Coffee, antioxidants, and brain inflammation
- Factors Influencing Discharges to Hospice for Patients With Late-Stage Huntington's Disease
- Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis
- Scheduled feeding improves sleep in a mouse model of Huntington's disease
- The impact of COVID-19 pandemic on patients with Huntington's disease and care-givers: A French survey
- Mechanism and treatment of intracerebral hemorrhage focus on mitochondrial permeability transition pore
- Comparing balance using the BESTest in Alzheimer, Huntington and Parkinson disease
- Exon 1-targeting miRNA reduces the pathogenic exon 1 HTT protein in Huntington disease models
- Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first-in-human study
- Peripheral sequestration of huntingtin delays neuronal death and depends on N-terminal ubiquitination
- Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" [Brain Behav. Immun. 120 (2024) 413-429]
- Identification of molecular targets and small drug candidates for Huntington's disease via bioinformatics and a network-based screening approach
- Economic Burden of Huntington's Disease: Analysis from a Brazilian Tertiary Care Perspective
- Coping with Huntington's Disease in Patients and At-Risk Individuals
- Fluorescence-Based Monitoring of Early-Stage Aggregation of Amyloid-β, Amylin Peptide, Tau, and α-Synuclein Proteins
- Nuclear poly-glutamine aggregates rupture the nuclear envelope and hinder its repair
- LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models
- Dysregulation of choline metabolism and therapeutic potential of citicoline in Huntington's disease
- Comprehensive identification of ubiquitin-like 3 (UBL3)-interacting proteins in the mouse brain
- Phenomenological patterns and aetiological spectrum in patients visiting a tertiary care Movement disorders service in India: An observational study
- Prognostic enrichment for early-stage Huntington's disease: An explainable machine learning approach for clinical trial
- The Frequency and Clinical Impact of Synonymous HTT Loss-of-Interruption and Duplication-of-interruption Variants in a Diverse HD Cohort
- Continuous bedside neuroimaging using high-density diffuse optical tomography in a pediatric patient on extracorporeal support
- PMS2 has both pro-mutagenic and anti-mutagenic effects on repeat instability in the Repeat Expansion Diseases
- Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
- TDP43 and Huntingtin Exon-1 Undergo A Conformationally Specific Interaction That Strongly Alters the Fibril Formation of Both Proteins
- The role of interferon beta in neurological diseases and its potential therapeutic relevance
- Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases
- Friend or foe: Lactate in neurodegenerative diseases
- Stress-Related Roles of Exosomes and Exosomal miRNAs in Common Neuropsychiatric Disorders
- Probiotic Functions in Fermented Foods: Anti-Viral, Immunomodulatory, and Anti-Cancer Benefits
- Metal Ion Binding to Human Glutaminyl Cyclase: A Structural Perspective
- Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms
- Prevalence of Juvenile-Onset and Pediatric Huntington's Disease and Their Availability and Ability to Participate in Trials: A Dutch Population and Enroll-HD Observational Study
- Advances in Gene and Cellular Therapeutic Approaches for Huntington's Disease
- Binding structures of SERF1a with NT17-polyQ peptides of huntingtin exon 1 revealed by SEC-SWAXS, NMR and molecular simulation
- Computerized Cognitive Training Increases Gray Matter Volumes in Huntington's Disease: A Pilot Study
- Psychiatric Manifestations of Neurological Diseases: A Narrative Review
- Linking coronary artery disease to neurodegenerative diseases through systems genetics
- Evidence-based review on symptomatic management of Huntington's disease
- Emerging pharmacological approaches for Huntington's disease
- Mutant Huntingtin Drives Development of an Advantageous Brain Early in Life: Evidence in Support of Antagonistic Pleiotropy
- The Princeton IV Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- Vascular Leukoencephalopathy Associated Chorea Due to A Heterozygous Htra 1 Variant: Novel Presentation of Cadasil Type II
- Epigenetics in rare neurological diseases
- An automatic measure for speech intelligibility in dysarthrias-validation across multiple languages and neurological disorders
- Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders
- Multi-omic analysis of Huntington's disease reveals a compensatory astrocyte state
- Simultaneous time-frequency analysis of gait signals of both legs in classifying neurodegenerative diseases
- Neuroprotection by ADAM10 inhibition requires TrkB signaling in the Huntington's disease hippocampus
- Interaction between resveratrol and SIRT1: role in neurodegenerative diseases
- Protein modification in neurodegenerative diseases
RSS Feed – Literature
HDinHD > RSS Feed – Literature
